IRIS
NAPOLI, Nicola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.717
EU - Europa 506
AS - Asia 187
OC - Oceania 1
SA - Sud America 1
Totale 2.412
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.717
SE - Svezia 218
CN - Cina 158
IT - Italia 109
UA - Ucraina 44
DE - Germania 37
GB - Regno Unito 32
FI - Finlandia 31
FR - Francia 18
SG - Singapore 13
BE - Belgio 12
VN - Vietnam 9
IN - India 7
IE - Irlanda 4
AR - Argentina 1
BG - Bulgaria 1
NZ - Nuova Zelanda 1
Totale 2.412
Salva come PNG Salva come JPEG
Città #
Fairfield 252
Chandler 208
Nyköping 160
Ashburn 127
Woodbridge 120
Houston 105
Seattle 103
Jacksonville 99
Ann Arbor 89
Cambridge 85
Wilmington 80
Beijing 49
New York 42
Lawrence 33
Roxbury 33
Nanjing 30
Des Moines 25
Brooklyn 24
Ostuni 20
Princeton 18
Nanchang 15
Bari 14
Boardman 14
Brussels 12
Dong Ket 9
Inglewood 9
Hanover 8
Shenyang 8
Jiaxing 7
Rome 7
Singapore 7
Hebei 6
San Diego 6
Tianjin 6
Helsinki 5
Zhengzhou 5
Changsha 4
Dearborn 4
Dublin 4
Guangzhou 4
London 4
Los Angeles 4
Noci 4
Pune 4
Taizhou 4
Taranto 4
Kunming 3
Ningbo 3
Paris 3
Redwood City 3
Andria 2
Baotou 2
Casalnuovo di Napoli 2
Cesa 2
Falls Church 2
Munich 2
Norwalk 2
Pistoia 2
San Pietro Vernotico 2
Shanghai 2
Vigodarzere 2
Washington 2
Auburn Hills 1
Auckland 1
Augusta 1
Casalnuovo Di Napoli 1
Chicago 1
Colle 1
Cordoba 1
Cosenza 1
Haikou 1
Hefei 1
Hounslow 1
Kilburn 1
Landshut 1
Modugno 1
Monmouth Junction 1
New Bedfont 1
Pozzallo 1
Prescot 1
Rivoli 1
San Martino Valle Caudina 1
San Mateo 1
Sirmione 1
Sofia 1
Soresina 1
Triggiano 1
Yong'an 1
Totale 1.942
Salva come PNG Salva come JPEG
Nome #
Hepatitis C virus clearance after direct-acting antivirals in cirrhotic patients by stages of liver impairment: the ITAL-C network study 128
Is hepatic lipogenesis fundamental for NAFLD/NASH? A focus on the nuclear receptor coactivator PGC-1β 112
A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital-c network study 110
HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study 109
Kikuchi-Fujimoto Disease in an Old Italian Woman: Case Report and Review of the Literature 108
Sierotipi del virus dell'epatite C e focalità tumorale in pazienti con cirrosi epatica HCV-correlata ed epatocarcinoma 105
SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience 104
A pegylated interferon alpha-2b dose-reduction in HCV 1b patients with rapid virological response does not affect sustained virological response 102
A case of sarcoidosis with isolated hepatosplenic onset and development of inflammatory bowel disease during recovery stage 102
Hepatocellular Carcinoma: Known and Emerging Risk Factors 97
Apoptotic effects of a chimeric plant virus carrying a mimotope of the hepatitis C virus hypervariable region 1: role of caspases and endoplasmic reticulum-stress. 94
Hepatocytes activate HSC via MMP-9. Role of IFN-a2b in modulating liver fibrosis in HCV patients 92
Hepatitis A virus and non-A, non-B virus superinfections in HBsAg chronic carriers. 82
Biliary Cystadenoma in a Female Patient with HCV-Related Liver Cirrhosis: A Case Report 82
Impairment of TLR7-dependent signaling in dendritic cells from chronic hepatitis C virus (HCV)-infected non-responders to interferon/ribavirin therapy 81
Hepatitis C virus infection in anti-HBe-positive HBsAg carriers with chronic liver disease 80
Tyrosine kinase inhibitors: a potential approach to the treatment of hepatocellular carcinoma 76
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency 76
Manifestazioni extraepatiche multiple in una paziente con epatite cronica C trattata con interferone-alfa 73
SCCA-IC serum levels are predictive of clinical response in HCV chronic hepatitis to antiviral therapy: a multicentric prospective study. 72
Occurrence of hepatitis delta virus infection in hepatitis B virus-infected patients with different serum patterns of preS geneencoded proteins 61
Antifibrogenic effect of IFN-alpha2b on hepatic stellate cell activation by human hepatocytes 58
Angiodisplasia gastrica di grave entità in un caso di porpore di Schonlein-Henoch 52
Predictive value of early virological response to treatment with different interferon-based regimens plus ribavirin in patients with chronic hepatitis C 51
Relationship between T lymphocyte responsiveness and T-helper1/T-helper2 type cytokine release in Chronic Hepatitis C: a critical reappraisal 49
Vasculite sistemica secondaria a trattamento con alfa-interferone in un soggetto con crioglobulinemia mista di tipo II 48
Asymptomatic systemic sarcoidosis arising 5 years after IFN-alfa treatment for chronic hepatitis C: a new challenge for clinicians 46
Analysis of hepatic stiffness after viral eradication in a population with chronic hepatitis C treated with DAAs 41
Clinical role of serum and tissue matrix metalloprotease-9 expression in chronic HCV patients treated with pegylated IFN-alpha2b and ribavirin 40
Ribavirin and high dose of interferon-alfa for retreatment of patients with chronic hepatitis C resistant to IFN alone 38
Relationship between HCV serotypes and tumor focality in HCV-infected cirrhotic patients with HCC 35
Liver fibrosis score, physical frailty, and the risk of dementia in older adults: The Italian longitudinal study on aging 33
Neutrophil apoptotic cell death: does it contribute to the increased infectious risk in aging? 26
The use of different Peg-interferon alpha-2b regimens plus ribavirin in HCV-1b-infected patients after rapid virological response does not affect the achievement of sustained virological response 26
Totale 2.489
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.587
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.587
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020495 0 34 16 57 60 32 54 50 69 37 73 13
2020/2021404 31 21 23 36 46 15 41 22 28 86 33 22
2021/2022309 22 33 1 13 27 54 12 13 16 13 49 56
2022/2023557 78 80 52 49 66 72 3 61 80 5 6 5
2023/2024205 11 36 10 36 15 66 6 8 1 1 3 12
2024/202526 21 5 0 0 0 0 0 0 0 0 0 0
Totale 2.489